Work

The evolving landscape of KRAS-targeted therapy: mechanisms of resistance and emerging strategies

Year: 2025

Type: article

Source: Anti-Cancer Drugs

DOI: 10.1097/cad.0000000000001801

Authors: Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla

Institutions: Brigham and Women's Hospital, Harvard University, University of California, San Francisco, Universidad Técnica de Ambato

Language: English

Topic: Protein Kinase Regulation and GTPase Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7117148233

FWCI: 0.52

Cites: 50

Cited by: 2

Related to: